22nd European Symposium on Quantitative Structure-Activity Relationships

  • Author/Organiser: Ismail Yalcin
  • Event Website: http://www.euroqsar2018.org/
  • Event Date: 16 September 2018 to 20 September 2018
  • Event Type: Conference
  • Venue: Thessaloniki, Greece

View Full Event Details

The event aims to to promote and disseminate advances in rational approaches in drug design and discovery and bring together scientists from both academia and industry. The conference theme is "Translational and Health Informatics: Implications for Drug Discovery".


Topics

  • ADME Prediction and Computational Toxicology for Safer and Efficacious Drugs
  • Big Data Analysis, Cloud Resources and Precision Medicine
  • Binding Kinetics in Drug Discovery
  • Biotechnology Targeted Drug Discovery
  • Cheminformatics / Pharmacoinformatics in the Era of Biological Complexity
  • Computational Biology and Quantum Enzymology
  • Computational Methods for Nanotechnology in Drug Discovery
  • Epigenetic Drug Targets
  • Homology Modelling for Drug Discovery
  • Ligand-Based and Structure-Based Approaches to Drug Design
  • Modelling of Natural Drugs
  • Molecular Dynamic Simulations and Related Methods
  • Multi-Targeting Drug Design
  • New avenues in QSAR Methodology and Applications
  • Protein Target Dynamics for Drug Discovery
  • Targeting Protein-Protein Interactions


Selected Speakers

  • Prof. Maurizio BOTTA, University of Siena, Siena, Italy
  • Dr. Dimitris AGRAFIOTIS, Chief Data Officer & Head of Technology Products, Covance / LabCorp Princeton, NJ, USA
  • Prof. Andrea CAVALLI, Professor of Medicinal Chemistry at the University of Bologna and Research Director at the Italian Istitute of Tecnology, Italy
  • Prof. Amiram GOLDBLUM, Head, Molecular Modeling and Drug Design, Institute for Drug Research, The Hebrew University of Jerusalem, Israel
  • Prof. Renate GRIFFITH, School of Medical Sciences, The University of New South Wales (UNSW), Sydney, Australia
  • Prof. William L. JORGENSEN, Editor JCTC, Sterling Professor of Chemistry, Department of Chemistry, Yale University, New Haven, USA
  • Prof. Johannes KIRCHMAIR, Applied Bioinformatics, University of Hamburg, Germany
  • Dr. Eric MARTIN, Director, Computational Chemistry, Novartis Institutes for BioMedical Research, Inc., Emeryville, CA, USA
  • Dr. Jonathan MASON, Head of Computational Chemistry & Chief Scientist, Heptares Therapeutics & Lundbeck, Welwyn Garden City, UK & Copenhagen, Denmark
  • Prof. Kenneth M. MERZ, Editor-in-Chief of JCIM. Director, Institute for Cyber Enabled Research (ICER), Joseph Zichis Chair in Chemistry, Department of Chemistry, Department of Biochemistry and Molecular Biology, Michigan State University, USA
  • Dr. Jordi MESTRES, IMIM Hospital del Mar Medical Research Institute Barcelona, Barcelona, Spain
  • Prof. Adrian J. MULHOLLAND, School of Chemistry, University of Bristol, UK
  • Prof. Tudor OPREA, Chief, Translational Informatics Division, Department of Internal Medicine, Health Sciences Center, The University of New Mexico, USA
  • Prof. Matteo Dal PERARO, Biomolecular Modeling group at EPFL in Lausanne, Switzerland
  • Dr. Veer SHANMUGASUNDARAM, Director & Head of Computational Analysis and Design Discovery Sciences, Pfizer, Groton, USA
  • Prof. Alexander TROPSHA, Assoc. Dean for Pharmaco-informatics and Data Science, K.H. Lee Distinguished Professor, Eshelman School of Pharmacy, Univ. North Carolina, USA
  • Dr. Marco de VIVO, Molecular Modeling & Drug Discovery Lab, Italian Istitute of Tecnology, Genoa, Italy
  • Prof. Renxiao WANG, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, Shanghai, China
  • Prof. David WINKLER, Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia
  • Prof. Gerhard WOLBER, Pharmaceutical Chemistry,Free University of Berlin, Germany

 

Article Views: 321

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH